Targeting tumor cells by radiotherapy and chemotherapy causes the release of damage-associated molecular pattern (DAMP) molecules such as high mobility group box 1 (HMGB1) as a result of necrotic cell death [8,9,10,11], and it has been found that HMGB1 triggers immune responses [12,13]. The gene discussed is HMGB1; the disease is neoplasm.